Skip to main content
. Author manuscript; available in PMC: 2018 Aug 24.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):185–189. doi: 10.1097/WAD.0000000000000250

Table 1.

Demographic and Clinical Characteristics.

NP NFT

No or Sparse NPs Moderate NPs Frequent NPs No NFTs or B&B Stage I or II B&B Stage III or IV B&B Stage V or VI

N = 392 N = 142 N = 132 N = 310 N = 262 N = 90
N / Mean % /SD N / Mean % /SD N / Mean % /SD N / Mean % /SD N / Mean % /SD N / Mean % /SD
Age at Last Clinical Visit 82.36 11.17 85.35 * 8.65 82.72 8.61 79.73 11.32 86.76 * 7.79 83.53 * 9.15
Age at Death 83.23 11.14 86.10 * 8.59 83.59 8.53 80.60 11.32 87.57 * 7.68 84.39 * 9.09
Interval Between Last Clinical Visit and Death 10.26 5.78 9.71 5.76 10.52 5.68 10.25 5.96 10.24 5.71 10.24 5.33
Sex
Male 199 51% 84 59% 71 54% 172 55% 128 48% 54 60%
Education (Years) 15.48 2.73 15.84 3.02 16.01 3.02 15.69 2.76 15.40 2.96 16.40 2.81
MMSE Score 27.61 1.86 27.14 1.88 26.73 * 1.92 27.74 1.91 27.24 * 1.82 26.28 * 1.92

NP, neuritic plaques; NFT, neurofibrillary tangles; B&B stage, Braak and Braak stage of NFT; MMSE, mini mental state examination.

Moderate and frequent NP group was independently analyzed against no or sparse NP. B&B stage III or IV or stage V or VI group was independently analyzed against no NFT or stage I or II.

*

p ≤0.005, Bonferroni correction for multiple comparisons.